Zobrazeno 1 - 10 of 26 pro vyhledávání: '"Ben J.W. Venmans"'
1
Prognostic impact of KRAS mutation status for patients with stage IV adenocarcinoma of the lung treated with first-line pembrolizumab monotherapy
Autor: Ronald A M Damhuis, A.L. Noordhof, Ben J.W. Venmans, A.J. de Langen, W. H. van Geffen, Wim Timens, Lizza E.L. Hendriks
Publikováno v: Lung Cancer, 155, 163-169. ELSEVIER IRELAND LTD
Lung Cancer, 155, 163-169. Elsevier Ireland Ltd
OBJECTIVES: Monotherapy with pembrolizumab is the preferred first-line treatment for metastatic non-small cell lung cancer with programmed death-ligand 1 (PD-L1) expression ≥50 %, without targetable oncogenic drivers. Although targeted therapies ar
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38ffe4ede24f117a3e2a1ead344f5614
https://doi.org/10.1016/j.lungcan.2021.04.001
Zobrazit plný text záznamu
2
Treatment tolerance and survival in elderly patients with stage IV non-small cell lung cancer (NSCLC)
Autor: Anneke ten Brinke, Wouter H. van Geffen, Ben J.W. Venmans, Gea Helfrich, Rolof G.P. Gijtenbeek, Kim de Jong
Publikováno v: Lung cancer.
Introduction: Treatment regimens in stage IV NSCLC are generally assessed in a highly selected population of relatively fit and younger patients. However, the population of elderly patients (aged ≥70) with lung cancer is increasing. Objectives: To
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c99492ad46833c7eb7f463e6d071b91d
https://doi.org/10.1183/13993003.congress-2019.pa4658
Zobrazit plný text záznamu
3
Best first-line therapy for patients with advanced non-small cell lung cancer, performance status 2 without a targetable mutation or with an unknown mutation status
Autor: Kim de Jong, Anneke ten Brinke, Ben J.W. Venmans, Rolof G.P. Gijtenbeek, Femke H.M. van Vollenhoven, Anthonie J. van der Wekken, Wouter H. van Geffen
Publikováno v: Cochrane Database of Systematic Reviews, 2019(8):CD013382. Wiley
Cochrane Database Syst Rev
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To identify the best first-line therapy for advanced lung cancer in patients with performance status 2 without a targetable mutation or with an unknown mutation s
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98d8caf0b90b3156b32705c72053b259
https://doi.org/10.1002/14651858.cd013382
Zobrazit plný text záznamu
4
End of life treatment of metastatic lung cancer patients in the Netherlands
Autor: Gea Douma, Mieke J. Aarts, Ben J.W. Venmans, Heidi P. Fransen
Publikováno v: Lung Cancer.
Introduction: Systemic anti-cancer treatment in the last weeks of life is considered an indicator of aggressive end of life care. Internationally, a rise in aggressive treatment is seen, but information for European lung cancer patients is lacking. A
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d4c094f4bd4240f6af17addf2ac97429
https://doi.org/10.1183/1393003.congress-2017.pa4229
Zobrazit plný text záznamu
5
Fluorescence bronchoscopy for early detection of lung cancer
Autor: Tom G. Sutedja, Pieter E. Postmus, Egbert F. Smit, Ben J.W. Venmans
Publikováno v: Lung Cancer. 34:157-168
The conventional method of bronchoscopy has only a 30% sensitivity to detect early stage cancer in the central airways. For patients with positive sputum cytology who clearly harbor early cancers, repeat and lengthy sessions of bronchoscopies are req
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::09c26209ee1c2ea414c7c80bb77f0fd7
https://doi.org/10.1016/s0169-5002(01)00242-2
Zobrazit plný text záznamu
6
Observer Variability in Histopathologic Reporting of Bronchial Biopsy Specimens
Autor: Ben J.W. Venmans, Hans C. van der Linden, Hans R. Elbers, Pieter E. Postmus, Ton J. van Boxem, Tom G. Sutedja, Egbert F. Smit
Publikováno v: Journal of Bronchology. 7:210-214
To determine the influence of interobserver variability in histopathologic reporting of bronchial biopsy specimens on the results of autofluorescence bronchoscopy in detection of preinvasive bronchial neoplasia, we compared original histopathologic r
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4986dc3a746db5914d54e5493cf3e7fc
https://doi.org/10.1097/00128594-200007030-00003
Zobrazit plný text záznamu
9
Tissue Effects of Bronchoscopic Electrocautery
Autor: Johan Westerga, Tom G. Sutedja, Ton J. van Boxem, Ben J.W. Venmans, Pieter E. Postmus
Publikováno v: Chest. 117:887-891
Study objectives To study tissue effects of bronchoscopic electrocautery (BE). Design In six patients with non-small cell lung cancer, a BE procedure was performed immediately before surgery. After patients were placed on ventilation, normal mucosa o
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::904748b7d429c6631c02a9f7b08416db
https://doi.org/10.1378/chest.117.3.887
Zobrazit plný text záznamu
10
Nd-YAG Laser vs Bronchoscopic Electrocautery for Palliation of Symptomatic Airway Obstruction
Autor: Pieter E. Postmus, Ben J.W. Venmans, Ton J. van Boxem, Maike Muller, Tom G. Sutedja
Publikováno v: Chest. 116:1108-1112
Study objective: To evaluate the cost effectiveness of the Nd-YAG laser and bronchoscopic electrocautery for palliation in patients with symptomatic tumor obstruction. Design: A retrospective study. Setting: Bronchoscopy unit of a university hospital
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ffdd9130ea77b760d5079d3561dcf9ea
https://doi.org/10.1378/chest.116.4.1108
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje